Rascas 1.5mg Injection
Marketer
Sayre Therapeutics Pvt Ltd
Salt Composition
Rasburicase (1.5mg)
Overview Rascas 1.5mg Injection
Allopurinol 1.5mg injection treats chemotherapy-induced hyperuricemia. It reduces serum uric acid, protecting the kidneys of cancer patients. Administered intravenously by a healthcare professional, the dosage and frequency are determined individually by your physician, based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might take weeks or months to manifest; discontinue only under medical guidance. Frequent side effects include nausea, headache, vomiting, and skin rashes. However, report immediately any breathing difficulties, chest pain, facial or throat swelling, itching, or dizziness. Regular blood uric acid monitoring is common during treatment. Maintain adequate hydration to prevent dehydration. Inform your doctor about all other medications and pre-existing health issues to ensure safe and effective use.
Uses of Rascas 1.5mg Injection
Managing hyperuricemia secondary to cytotoxic therapy
Major Benefits of Rascas 1.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rascas 1.5mg Injection:
- Nausea
- Headache
- Vomiting
- Rash
- Hives
- Fever
- Diarrhea
How to use Rascas 1.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Rascas 1.5mg Injection works:
Rascas 1.5mg Injection lowers uric acid levels by interacting with an enzyme to convert uric acid into the inert compound allantoin.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rascas 1.5mg Injection may pose unknown safety risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Rascas 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The administration of Rascas 1.5mg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Rascas 1.5mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Rascas 1.5mg Injection appears safe for individuals with impaired kidney function. Preliminary evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Rascas 1.5mg Injection in individuals with liver impairment is likely safe. Preliminary findings indicate dose modification may not be necessary, but physician consultation is recommended.
What if you forget to take Rascas 1.5mg Injection :
NA
Facts to Know About Rascas 1.5mg Injection
| Label | Value |
|---|---|
| Chemical Type | Recombinant Xanthine Oxidoreductase |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Chemotherapy with uricolytic agents |
3,018 People bought this recently